| General information of recruited subjects |  |
---|---|---|
Age | 64.6 ± 9.6 years (Range: 50–92) |  |
Gender ratio (F:M) | 83:66 | Â |
 | Information of subjects positively diagnosed with | Information of subjects negatively diagnosed with | P-value of age | P-value of gender ratio (Chi square test) | ||||
---|---|---|---|---|---|---|---|---|
No. of subject | Age | Gender ratio (F:M) | No. of subject | Age | Gender ratio (F:M) | |||
Metabolic Syndrome | 75 | 62.29 ± 7.17 | 41:34 | 74 | 67.03 ± 11.09 | 42:32 | 0.002 | 0.797 |
Hypertension | 61 | 63.03 ± 7.45 | 37:24 | 88 | 65.76 ± 10.73 | 46:42 | 0.069 | 0.331 |
Central Obesity | 69 | 62.94 ± 7.02 | 36:33 | 80 | 66.11 ± 11.19 | 47:33 | 0.038 | 0.420 |
Hypertriglyceridemia | 101 | 64.18 ± 7.80 | 54:47 | 48 | 65.63 ± 11.12 | 29:19 | 0.431 | 0.425 |
Dyslipidemia (low HDL-C) | 94 | 61.34 ± 7.08 | 50:44 | 55 | 70.29 ± 10.70 | 33:22 | 0.001 | 0.419 |
Hyperglycemia | 103 | 64.29 ± 8.91 | 60:43 | 46 | 65.43 ± 11.03 | 23:23 | 0.538 | 0.349 |